Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
A UK-based Novo Nordisk employee reposted an FT LinkedIn post linking to positive claims about Wegovy and Ozempic. The Panel found disguised…
A UK-based AstraZeneca employee ‘liked’ a US colleague’s LinkedIn post linking to a Breztri press release. The Panel ruled this proactively disseminated…
A third‑party promotional email for Nustendi quoted a “38% LDL‑C reduction (placebo‑corrected)”. The PMCPA ruled the layout implied this was vs ezetimibe…
Complaint alleged a NICE COPD treatment algorithm on a Trelegy promotional webpage indirectly promoted Anoro/Relvar without prescribing information. PMCPA ruled the page…
PMCPA found Otsuka’s Jinarc training portal gave contradictory messages about enrolment being required to prescribe, and an HCP educational guide omitted a…
At ECCMID 2022, a UK HCP presentation was ruled promotional for Spikevax and included booster-dose data inconsistent with the SPC. Breaches: Clauses…
Complaint alleged Wegovy was promoted at a Scotland meeting to NI HCPs before NI marketing authorisation. Panel found Wegovy had MA in…
Employee alleged Auxilium CRT (a MEGS) was used as disguised promotion to boost Imfinzi during COVID-19 and reflected poor culture. PMCPA Panel…
PMCPA found Novo Nordisk breached Clauses 2, 5.1/9.1 and 28.1 over pharmacy-chain sponsorships that weren’t truly arm’s length, free consumables seen as…
A third-party LinkedIn post named four AstraZeneca oncology POMs. UK-based AstraZeneca employees ‘liked’ it, which the Panel said disseminated promotional content to…
Takeda’s HCP-only Rare Disease Hub website was ruled in breach for not displaying the required adverse event reporting statement prominently. Other allegations…
Two sponsored cardiovascular disease articles on a charity website disclosed Daiichi Sankyo’s involvement only at the bottom of long pages. PMCPA found…
PMCPA found Merck Serono failed to maintain high standards after two event co-chairs’ consultancy agreements were not agreed/signed in advance of services.…
A former creative agency posted about past work and referenced Emerade on social media. PMCPA ruled the agency was not a third…
A paediatrician at an NHS trial site circulated a WhatsApp recruitment message for Moderna’s NextCOVE trial offering £1,500 on completion. PMCPA found…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
